Article
Tumor necrosis factor-alpha gene polymorphism correlates with cardiovascular disease in patients with end-stage renal disease.
Molecular diagnosis & therapy - 1 Jan 2007
Buraczynska Monika, Mierzicki Piotr, Buraczynska Kinga, Dragan Michał, Ksiazek Andrzej
Abstract excerpt
BACKGROUND AND OBJECTIVE: Tumor necrosis factor-alpha (TNFalpha) is a potent proinflammatory cytokine. Through its effects on lipid metabolism and endothelial function, TNFalpha is involved in cardiovascular disease (CVD). We have studied two polymorphisms in the promoter region of the TNFalpha gene (TNF -308G/A and TNF -238G/A) in end-stage renal disease (ESRD) patients with and without CVD. The aim was to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
